Tabatt Pharmaeconomics OÜ
RegisteredKey figures
Ratios
2025/26Summary: Tabatt Pharmaeconomics OÜ
What kind of company is it?
Tabatt Pharmaeconomics OÜ (registry code 16021375) is a private limited company (OÜ). The company was entered in the Commercial Register in 2020 and has been registered for 6 years. Registered location: Haabersti linnaosa, Tallinn, Harju maakond. The company is registered for VAT (VAT number EE102280320).
How is the company doing financially?
There was no revenue in financial year 2025/26. Net profit for financial year 2025/26 was 246 714 €. The company was profitable in all 5 published financial years. According to the report, the company had no employees in financial year 2025/26. At the end of financial year 2025/26, total assets were 2 912 821 € and equity 2 836 713 € (97,4% of assets).
What do the latest quarters show?
According to the Tax and Customs Board, the company declared no turnover in Q3 2026.
Who runs the company and who owns it?
The company has one management board member. The sole owner of the company is a private individual.
Where does the data come from and how fresh is it?
Register data (name, address, legal form, management board and owners) come from the Commercial Register of the Centre of Registers and Information Systems (RIK); changes are read from RIK every night. Financial figures come from annual reports; the latest report (financial year 2025/26) was filed on 13.09.2026. Quarterly turnover, employee numbers and labour taxes come from the open data of the Tax and Customs Board (EMTA); latest quarter Q3 2026. Changes, averages and ratios are calculated by entity.ee from open data and are not an official assessment.
Quarterly figures
| Quarter | Revenue | Number of employees | Labour taxes |
|---|---|---|---|
| Q3 2026 | 0 € | 1 | — |
| Q2 2026 | 0 € | — | — |
| Q1 2026 | 0 € | — | — |
| Q4 2025 | 0 € | — | — |
| Q3 2025 | 0 € | — | — |
| Q2 2025 | 0 € | — | — |
| Q1 2025 | 0 € | — | — |
Source: Tax Board open data — based on VAT returns, may not exactly match revenue in the annual report. Updated quarterly.
Summary of financial statements2021–2025
| 2020/21 | 2022/23 | 2023/24 | 2024/25 | 2025/26 | |
|---|---|---|---|---|---|
| Sales revenue | 86 250 | 41 100 | 0 | 39 474 | 0 |
| Net profit | 90 195 | 601 550 | 193 288 | 356 621 | 246 714 |
| Retained earnings | — | 90 195 | 691 745 | 885 034 | 1 241 656 |
| Total assets | 1 430 283 | 2 062 288 | 2 380 472 | 2 674 106 | 2 912 821 |
| Total liabilities | 169 580 | 192 535 | 147 096 | 84 108 | 76 108 |
| Total equity | 1 260 703 | 1 869 753 | 2 233 376 | 2 589 998 | 2 836 713 |
| Employees | 0 | 0 | 0 | 0 | 0 |
| Calculated dividend | — | — | 0 | 0 | 0 |
A dash (—) means the report has not been filed or the line is not reported; 0 is a zero stated in the report.
Risks and obligationsAll clear
Data from public registers, not a credit rating.
Connections graph
Click a node to see its other connections.
Change history
1 change- 12.10.2026*Annual report 2025 filed
Entered in the register on 03.08.2020.
Source: Business Register change list and open data. * date the change was detected in open data (it happened between this and the previous data update).
Annual reportsPDF, XBRL
Loading list of reports…
Source: e-Business Register (RIK). Files open/download directly from the official register.